Danaher reports Q3 2026 financial results
The company achieved $1.2 billion in net earnings and raised its full-year adjusted EPS guidance to $8.57-$8.62.
See the latest news and media coverage for Danaher. We track all announcements, press releases, and industry mentions in real time, all in one place.
Life sciences and diagnostics innovator
danaher.comLast updated
In short: Danaher reported $1.2 billion in Q3 net earnings and raised its 2026 adjusted EPS guidance.
The company achieved $1.2 billion in net earnings and raised its full-year adjusted EPS guidance to $8.57-$8.62.
She joins the Board of Directors succeeding Rainer Blair who serves as a senior advisor until March 2027 to ensure a seamless transition.
Rainer Blair will retire effective October 1, 2026; Montgomery has led Diagnostics and brings 25 years of experience.
The clearance covers the first brain-monitoring sedation score for children, aiding clinicians in decision-making.
The Washington, DC, life-sciences, biotechnology and diagnostics company posted earnings of $1.24 billion, or $1.75 a share, for the quarter ended Sept. 25, up from...
Danaher posted its first full quarter after its acquisition of Masimo, which fueled a 16.5% boost in its diagnostics segment.
Danaher and NVIDIA are working to integrate AI into scientific instruments through edge computing like NVIDIA DGX Spark, accelerated analytics and data processing with RAPIDS...
According to MarketBeat, Danaher reported its second-quarter results on July 20, 2026, with EPS of USD 1.94 versus analyst expectations of USD 1.85. The USD...
Track Danaher and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Danaher and other trending companies.